Bone histomorphometry of transiliac paired bone biopsies after 6 or 12 months of treatment with oral strontium ranelate in 387 osteoporotic women: randomized comparison to alendronate.
about
Treatment of primary osteoporosis in menThe Beneficial Effects of Bisphosphonate-enoxacin on Cortical Bone Mass and Strength in Ovariectomized Rats.Strontium ranelate improves delayed healing of osteolytic lesions of the jaw in a man with chronic osteomyelitis. Case reportEffect of sequential treatments with alendronate, parathyroid hormone (1-34) and raloxifene on cortical bone mass and strength in ovariectomized rats.Strontium inhibits titanium particle-induced osteoclast activation and chronic inflammation via suppression of NF-κB pathway.Bone markers and osteoporosis therapy.Novel targets for the prevention of osteoporosis - lessons learned from studies of metabolic bone disorders.Management of beta-thalassemia-associated osteoporosis.Thalassemia-associated osteoporosis: a systematic review on treatment and brief overview of the disease.A Longitudinal Study of Skeletal Histomorphometry at 6 and 24 Months Across Four Bone Envelopes in Postmenopausal Women With Osteoporosis Receiving Teriparatide or Zoledronic Acid in the SHOTZ Trial.The incorporation of fluoride and strontium in hydroxyapatite affects the composition, structure, and mechanical properties of human cortical bone.Strontium ranelate stimulates trabecular bone formation in a rat tibial bone defect healing process.The utility of bone scintigraphy in the assessment of mandibular metabolism during long-term bisphosphonate administration.Site specific measurements of bone formation using [18F] sodium fluoride PET/CT.Human mesenchymal stromal cells response to biomimetic octacalcium phosphate containing strontium.The challenges of diagnosing osteoporosis and the limitations of currently available tools.
P2860
Q26991748-30B6B72F-95CF-4756-923B-3823F2C34580Q33770077-48C2765E-BA1A-4C56-BF0D-65F08F081B85Q33781635-456D07AC-5CD6-41EF-8828-416C76039FDDQ34149279-12275DCA-DDE9-45EA-AB2F-2B279B64D5D2Q37379999-01E1D1B1-946D-409D-ADCB-49B458B89C8CQ38244170-1E4BD893-32A8-4C70-8C26-67B71D605B31Q38470745-0C2C867F-CE82-4B62-8A1C-7CEDDF520E1DQ38802918-94D7DEB4-E6D3-4208-A169-9962D978A3B7Q38922341-7DEAF0D8-ABB6-4C7E-B21C-1121DB6738BEQ40027774-6F2D3DC8-104A-45D6-912F-F39E12DB6FC1Q46276556-F150CFDD-CEEA-4419-8612-C152140443CBQ47626467-EFCC6492-A7CE-472E-A21B-48F358405E58Q48283409-2D130CE8-8807-4910-9C88-8503C9769DCAQ52654951-0752A349-F45B-4E47-8445-679646C230DDQ53137926-8065B421-5806-4DB4-AA6D-5F6683CED79BQ55113719-96FAEDB4-E4ED-4F02-ADEE-79F8FF9277A7
P2860
Bone histomorphometry of transiliac paired bone biopsies after 6 or 12 months of treatment with oral strontium ranelate in 387 osteoporotic women: randomized comparison to alendronate.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
Bone histomorphometry of trans ...... zed comparison to alendronate.
@en
Bone histomorphometry of trans ...... zed comparison to alendronate.
@nl
type
label
Bone histomorphometry of trans ...... zed comparison to alendronate.
@en
Bone histomorphometry of trans ...... zed comparison to alendronate.
@nl
prefLabel
Bone histomorphometry of trans ...... zed comparison to alendronate.
@en
Bone histomorphometry of trans ...... zed comparison to alendronate.
@nl
P2093
P2860
P356
P1476
Bone histomorphometry of trans ...... ized comparison to alendronate
@en
P2093
Marlène Pierre
Nathalie Portero-Muzy
Pascale Chavassieux
Pierre J Meunier
Roland Chapurlat
P2860
P304
P356
10.1002/JBMR.2074
P577
2014-03-01T00:00:00Z